Related Experiment Video
Updated: Feb 9, 2026

08:00
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
Published on: October 11, 2019
8.0K
Expression of eukaryotic initiation factor 4E in astrocytic tumors
Xin Gu1, Lamar Jones, Mary Lowery-Norberg
1Department of Pathology, Louisiana University Health Sciences Center-Shreveport, Shreveport, LA 71130, USA. xgu@lsuhsc.edu
Summary
The eukaryotic initiation factor 4E (eIF4E) protein is upregulated in high-grade brain tumors like astrocytoma and glioblastoma. This suggests eIF4E may be a therapeutic target for brain tumor treatment.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Research
Background:
- Upregulation of eukaryotic initiation factor 4E (eIF4E) is observed in various cancers, including breast, head and neck, and bladder carcinomas.
- eIF4E plays a crucial role in protein synthesis and is implicated in neoplastic transformation and tumor progression.
Purpose of the Study:
- To investigate the expression of eIF4E protein in human brain tissues, including normal brain, anaplastic astrocytoma, and glioblastoma multiforme.
- To determine the potential role of eIF4E in the pathogenesis of high-grade astrocytic tumors.
Main Methods:
- Immunohistochemical analysis of eIF4E protein expression in human brain tissue samples.
- Comparison of eIF4E expression levels between normal brain tissue and malignant astrocytoma samples.
Main Results:
- eIF4E protein expression was detected in normal pyramidal neurons but not in neuroglial cells.
- Diffuse and uniform eIF4E immunoreactivity was observed in malignant astrocytes of anaplastic astrocytoma and glioblastoma multiforme.
- Proliferative and vascular endothelial cells in glioblastoma multiforme also showed eIF4E immunoreactivity.
Conclusions:
- eIF4E is significantly upregulated in high-grade astrocytic tumors (anaplastic astrocytoma and glioblastoma multiforme).
- Elevated eIF4E levels may contribute to neoplastic transformation, angiogenesis, and tumor growth in astrocytic tumors.
- eIF4E represents a potential therapeutic target for adjuvant therapy in brain tumors.
Related Concept Videos
Eukaryotic RNA Polymerases
27.2K
RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
All three eukaryotic RNAPs require specific transcription factors, of which the...
27.2K
Initiation of Translation
39.1K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.1K
Initiation of Translation
8.1K
No description available
8.1K
The Eukaryotic Promoter Region
18.9K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.9K
Replication in Eukaryotes
205.6K
Overview
205.6K
Transcription Factors
82.8K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.8K

